Groundbreaking Ceremony for Tridem Pharma's New French Headquarter and European Distribution Center to Build A Leading Intelligent Drug Distribution Platform in Europe

Release time:2022-10-27 Content sourced from: Page View:
(October 27, 2022, Belberaud, France and Shanghai, China) On October 25, 2022 (local time), the groundbreaking ceremony for the new French Headquarter and European Distribution Center of Tridem Pharma, a Fosun Pharma company (Stock code: 600196.SH; 02196.HK), was successfully held in Belberaud, a city in south France. It marks a solid step for Tridem Pharma towards the goal of building a leading distribution platform of pharmaceutical and healthcare products in Europe, the Middle East and Africa!

Rafael Sorroche (Mayor of Belberaud), Su Li (Vice President of Fosun Pharma and CEO of Tridem Pharma), representatives from the government of Belberaud and regional megalopolis public community (SICOVAL), the supply chain team of Fosun Pharma Digital Technology and Innovation Department employees of Tridem Pharma French Headquarter, as well as honored guests, representatives of local project supplier and the construction contractor, attended the ceremony.

The new French Headquarter and European Distribution Center of Tridem Pharma covers an area of 3 hectares and includes office buildings and warehouses equipped with Automatic Storage&Retrieval System. With the concept of environmental friendly, the office buildings are designed of 1,563 m2, intending to provide Tridem Pharma employees to work in a relaxed and comfortable environment through simple and flexible office space and auxiliary facilities. The 9,817 m2standard warehouses and cooling warehouses will be equipped with automatic storage&retrieval system,which enables it to accommodate maxim 14,000 pallets. The Dematic warehouse management system will connect the warehouses to the Tridem Pharma's supply chain system through SAP S4HANA. Once constructed, the new Tridem Pharma French distribution center will be able to provide professional, efficient and convenient drug storage and distribution services for customers in Europe and Africa.

Established in 1986, Tridem Pharma is a major player in distribution of pharmaceutical products in Africa. Tridem Pharma joined the Fosun Pharma familiy in 2017. It presents in 35 Africa countries through 9 subsidiaries and 8 branch offices, with 900 employees in Africa, France, China and India. Tridem Pharma’s business covers nearly 90% of Africa.

Fosun Pharma is committed to make Tridem Pharma a globally competitive distribution platform for pharmaceutical and healthcare products worldwide. In the future, Tridem Pharma's European Distribution Center will not only serve as a transfer station for products from all over the world to enter the French-speaking Africa countries, but also help Tridem Pharma to expand its distribution capabilities in France and even throughout Europe, which will enable Tridem Pharma to provide one-stop shop solutions for pharmaceutical and healthcare products to be distributed in Africa, Europe and the Middle East.


About Fosun Pharma
Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"; stock code: 600196. SH, 02196. HK) is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China. Fosun Pharma directly operates businesses including pharmaceutical manufacturing, medical devices, medical diagnosis, and healthcare services. As a shareholder of Sinopharm Co., Ltd., Fosun Pharma expands its areas in the pharmaceutical distribution and retail business.

Fosun Pharma is patient-centered and clinical needs-oriented. The company enriches its innovative product pipeline through diversified and multi-level cooperation models such as independent research and development, cooperative development, license-in, and in-depth incubation. Fosun Pharma has formed technological platforms for innovative small molecule drugs, antibody drugs, and cell therapy with a focus on key disease areas including oncology and immunomodulation, metabolism and digestive system, as well as central nervous system. Fosun Pharma also vigorously explores cutting-edge technologies, such as RNA, gene therapy, ADC and PROTAC, to enhance its innovation capabilities.

Guided by the 4IN strategy (Innovation, Internationalization, Intelligentization, and Integration), Fosun Pharma will uphold the development model of “innovation transformation, integrated operation, and steady growth", with the mission of creating shareholder values through strengthening its independent R&D and external cooperation and enriching its product pipelines, as well as promoting the global networks and enhancing operational efficiency. Fosun Pharma will actively promote the digital and physical business layout in the pharmaceutical and healthcare industry and is committed to becoming a first-class enterprise in the global medical and health market.

For more information, please visit our official